| 2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선 |
| 2016 | | Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads | 전미선 |
| 2017 | | Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
| 2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
| 2020 | | Loco-regional outcomes of adjusted breast radiotherapy with conventional fractionation after breast conserving surgery: De-escalation of whole breast irradiation dose | 노오규, 오영택, 전미선 |
| 2007 | | Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. | 강석윤, 강승희, 김장희, 김효철, 박준성, 신승수, 오영택, 이광재, 이현우, 전미선, 최진혁, 한재호 |
| 2017 | | Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) | 전미선 |
| 2015 | | Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy. | 오영택 |
| 2011 | | Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: a single institution's experience over 14 years. | 김우영, 유승철, 유희석, 장기홍, 장석준, 전미선 |
